Programme
The programme for all invited keynote speakers can be viewed below.
All times given are in UTC/GMT. To see a time in your time zone, please use the converter below.
All sessions are recorded for prime time viewing in all time zones!
All submitted talks will be grouped into the programme after the submission deadline.
- Day 01 | Wednesday, 16 June
- Day 02 | Thursday, 17 June
- Day 03 | Friday, 18 June
- Submitted Talks
Plenary 1: SARS-CoV-2: evolution and control Session Chairs: Deyin Guo and Zhengli Shi | ||
Time (UTC/GMT) | Speaker, Institute, Country | Topic |
12:45 – 13:00 | Maria Söderlund-Venermo: WSV Vice President, Europe, and Head of the Scientific Organising Committee Ahmed Sayed Abdel-Moneim: WSV Founding President Richard Kuhn: WSV President-Elect Anupam Varma: WSV President | Welcome session |
13:00 – 13:05 | Introduction of keynote speakers | |
13:05 – 13:30 | Zhengli Shi, Wuhan Institute of Virology, China | From SARS-CoV to SARS-CoV-2, understanding of interspecies infection of bat coronaviruses |
13:30 – 13:55 | Marion Koopmans, Erasmus Medical Centre, Netherlands | Searching for the origins of SARS-CoV-2 |
13:55 – 14:20 | Neil M Ferguson, Imperial College London, UK | How vaccines and variants are shaping epidemiology and policy in the COVID-19 pandemic |
14:20 – 14:45 | Jerome Kim, International Vaccine Institute (IVI), South Korea | COVID-19 vaccines: Taking a shot beyond efficacy |
14:45 – 15:05 | Q&A common discussion for all 4 speakers | |
Plenary 2: COVID-19: pathogenesis and immune responses Session Chairs: Ziad Memish and Ilkka Julkunen | ||
15:20 – 15:25 | Introduction of keynote speakers | |
15:25 – 15:50 | Stanley Perlman, University of Iowa Health Care, USA | Animal models for COVID-19 |
15:50 – 16:15 | Bart Haagmans, Erasmus MC, Netherlands | Pathogenesis of SARS-CoV-2 |
16:15 – 16:40 | Kari Nadeau, Stanford University, USA | Reactive immune responses to COVID and its vaccines |
16:40 – 17:05 | Emilia Liana Falcone, Montréal Clinical Research Institute (IRCM), Canada | The post-COVID-19 condition: from clinical evaluation to pathophysiology through the researcher’s lens. |
17:05 – 17:25 | Q&A live common discussion for all 4 speakers. |
Plenary 3: From small to giant through the ages Session Chairs: Eric Delwart and Rosa Del Angel | ||
Time (UTC/GMT) | Speaker, Institute, Country | Topic |
13:00–13:05 | Introduction of keynote speakers | |
13:05–13:30 | Vincent Racaniello, Columbia University, USA | Enteroviruses and childhood paralysis |
13:30–13:55 | Chantal Abergel, CNRS, France | The concept of virus in the giant virus era |
13:55–14:20 | Edward Holmes, University of Sydney, Australia | The RNA virosphere: From ecosystems to emergence |
14:20–14:45 | Murilo Zerbini, ICTV, Brazil | Contagium vivum fluidum: Virus taxonomy from the origins of virology until the 21st century |
14:45–15:00 | Q&A common discussion for all 4 speakers | |
Parallel session 1: Avian and aquatic viruses Session Chairs: Mariana Baz and Vikram Vakharia | ||
15:15–15:20 | Introduction of keynote speakers | |
15:20–15:45 | Kanta Subbarao, University of Melbourne, Australia | Interspecies transmission of avian influenza viruses |
15:45–16:10 | Khatijah Yusoff, Universiti Putra Malaysia, Malaysia | Repurposing engineered Newcastle disease virus in modern vaccinology |
16:10–16:35 | Egbert Mundt, Boehringer Ingelheim, Germany | Infectious Bursal Disease Virus: Deep understanding of viral molecular biology supports controlling the disease |
16:35–17:00 | Øystein Evensen, Norwegian University of Life Sciences, Norway | Fish viral vaccines for global aquaculture |
17:00–17:15 | Q&A common discussion for all 4 speakers | |
Parallel session 2: Plant viruses Session Chairs: Anupam Varma and Hanu Pappu | ||
15:15–15:20 | Introduction of keynote speakers | |
15:20–15:45 | Neena Mitter, University of Queensland, Australia | RNAi in a drum: Can it work for viruses? |
15:45–16:10 | Kristiina Mäkinen, University of Helsinki, Finland | A viral ribonucleoprotein complex guards potato virus A RNA genome all the way from replication to stable particle formation |
16:10–16:35 | Hanu Pappu, Washington State University, USA | Continued threat of tospoviruses: New insights into virus-host interactions and RNAi strategies |
16:35–17:00 | James Van Etten, University of Nebraska-Lincoln, USA | Chloroviruses have a sweet tooth |
17:00–17:15 | Q&A common discussion for all 4 speakers | |
Parallel session 3: New winds in virus diagnostics Session Chair: Matthew Moore and Maria Söderlund-Venermo | ||
15:15–15:20 | Introduction of keynote speakers | |
15:20–15:45 | Klaus Hedman, University of Helsinki, Finland | FRET-POC – a revolutionary immunodiagnostic concept |
15:45–16:10 | Evgeny Nikolaev, Center for Translational Biomedicine, Skoltech, Russia | Identification of the SARS-CoV-2 virus by mass spectrometry |
16:10–16:35 | Christina Wege, University of Stuttgart, Germany | Plant virus-based nanotools: Novel functionality and shapes for biosensing |
16:35–17:00 | Cameron Myhrvold, Princeton University, USA | Massively multiplexed CRISPR-based viral diagnostics |
17:00–17:15 | Q&A common discussion for all 4 speakers |
Plenary 4: One Health, One World Session Chairs: Laura Kramer and Marietjie Venter | ||
Time (UTC/GMT) | Speaker, Institute, Country | Topic |
13:00-13:05 | Introduction of keynote speakers | |
13:05-13:30 | Curtis Suttle, University of British Columbia, Canada | Unveiling the virosphere |
13:30-13:55 | Andrea Marzi, NIAID Laboratory of Virology, USA | Fighting the beast – a vaccine against Ebola virus |
13:55-14:20 | Linda Saif, The Ohio State University, USA | COVID-19 and global emerging coronaviruses of humans and animals |
14:20-14:45 | Robert Gallo, University of Maryland, USA | HIV: Yesterday, Today and Tomorrow |
14:45-15:00 | Q&A live common discussion for all 4 speakers | |
Parallel session 1: Animal viruses Session Chairs: William Wilson and Michael Nevels | ||
15:15-15:20 | Introduction of keynote speakers | |
15:20-15:45 | Anne Balkema-Buschmann, Friedrich-Loeffler-Institut, Germany | Bats as reservoirs for henipaviruses |
15:45-16:10 | Marietjie Venter, University of Pretoria, South Africa | One Health investigations of West Nile virus lineage 2 in South Africa |
16:10-16:35 | Teresa de los Santos, Plum Island Animal Disease Center, USA | FMDV modulation of the host immune response |
16:35-17:00 | Covadonga Alonso, INIA, Spain | Insights in viral uncoating and fusion |
17:00-17:15 | Q&A live common discussion for all 4 speakers | |
Parallel session 2: Clinical virology Session Chairs: Flor Pujol and Kristina Broliden | ||
15:15-15:20 | Introduction of keynote speakers | |
15:20-15:45 | Heikki Hyöty, Tampere University, Finland | Enteroviruses and diabetes |
15:45-16:10 | Fabien Zoulim, Lyon University, France | The path towards a cure of chronic HBV infection |
16:10-16:35 | Jean Rommelaere, DKFZ, Germany | Tumor suppression by oncolytic parvoviruses: from bench to bedside and back |
16:35-17:00 | Stephanie Karst, University of Florida, USA | Host and microbial regulation of norovirus pathogenesis |
17:00-17:15 | Q&A live common discussion for all 4 speakers | |
Parallel session 3: Phage and insect viruses Session Chair: Yigang Tong and Mylene Ogliastro | ||
15:15-15:20 | Introduction of keynote speakers | |
15:20-15:45 | Karyn Johnson, University of Queensland, Australia | Antiviral defences in insects: The impact of miRNA |
15:45-16:10 | Myléne Ogliastro, University of Montpellier, France | Densoviruses for insect biocontrol: something old, something new |
16:10-16:35 | Sylvain Moineau, Université Laval, Canada | The ongoing battle between phages and CRISPR-Cas systems |
16:35-17:00 | Mzia Kutateladze, Eliava Institute, Georgia | Phage Therapy: Experience and Perspectives |
17:00-17:15 | Q&A live common discussion for all 4 speakers |